Treatment of older persons with hypercholesterolemia with and without cardiovascular disease

Area of Science:

• Cardiology
• Pharmacology
• Geriatrics

Background:

• Hypercholesterolemia is a significant risk factor for new coronary events in older adults.
• Secondary prevention trials confirm statins' benefits in patients with coronary artery disease (CAD) and hypercholesterolemia.

Purpose of the Study:

• To evaluate the efficacy of statin therapy in older men and women for both secondary and primary prevention of cardiovascular events.
• To establish treatment guidelines for statin use based on cholesterol levels and existing cardiovascular conditions.

Main Methods:

• Review of secondary prevention trials demonstrating statins' impact on mortality, cardiovascular events, and disease progression in patients with CAD.
• Analysis of primary prevention data, including the Air Force/Texas Coronary Atherosclerosis Prevention Study, to assess statins' effectiveness in older individuals without established cardiovascular disease.

Main Results:

• Statins significantly reduce all-cause mortality, cardiovascular mortality, coronary events, stroke, and intermittent claudication in older individuals with CAD.
• In secondary prevention, statins slow coronary plaque progression, reduce restenosis post-stenting, and decrease myocardial ischemia.
• For primary prevention, statins are effective in reducing cardiovascular events in individuals aged 65-80 with LDL cholesterol >130 mg/dl and HDL cholesterol <50 mg/dl.

Conclusions:

• Statin therapy is recommended for older individuals with CAD and hypercholesterolemia to lower LDL cholesterol below 100 mg/dl.
• Physicians should consider statins for primary prevention in individuals aged 65-80 with elevated LDL cholesterol and low HDL cholesterol, even without pre-existing cardiovascular disease.